No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
# Background A recent study estimated that more than 1.5 million Americans have an indeterminate pulmonary nodule (IPN) identified on a chest computed tomography (CT) scan each year outside of lung cancer screening programs. However, the cost and pattern of subsequent IPN workup have not been descri...
Saved in:
| Main Authors: | Bruce S. Pyenson, Carol M. Bazell, Michael J. Bellanich, Melissa A. Caplen, Javier J. Zulueta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2019-05-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9674 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
by: Navjit Dharampal, et al.
Published: (2022-12-01) -
Expert consensus on the evaluation and management of high-risk indeterminate pulmonary nodules
by: Yang Dawei, et al.
Published: (2024-12-01) -
The Role of Ultrasound as a Predictor of Malignancy in Indeterminate Thyroid Nodules—A Multicenter Study
by: Reem J. Al Argan, et al.
Published: (2025-06-01) -
68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
by: Ronald Walker, et al.
Published: (2017-01-01) -
Beyond genomics: artificial intelligence-powered diagnostics for indeterminate thyroid nodules—a systematic review and meta-analysis
by: Karishma Jassal, et al.
Published: (2025-05-01)